Vimarsana
Biggest News Aggregation in the World

Page 29 - Iontech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iontech Today - Breaking & Trending Today

A Pfizer Leader Reveals the Company's Innovation Plans Around MRNA - Vimarsana News

A Pfizer Leader Reveals the Company's Innovation Plans Around MRNA

The COVID-19 vaccine unlocked the potential of mRNA technology and new ways of approaching problems, a senior vice president told Insider.

Coronavirus reproductive rate in Hong Kong falls below 1, signals possible outbreak wane, but officials say further monitoring needed - Vimarsana News

Coronavirus reproductive rate in Hong Kong falls below 1, signals possible outbreak wane, but officials say further monitoring needed

Estimated number of people infected by single patient stands at 0.98 as of September 7, marking first time rate has fallen below one since August 9.

Source: scmp.com
COVID-19: France approves Omicron-adapted vaccines for booster shot - Vimarsana News

COVID-19: France approves Omicron-adapted vaccines for booster shot

COVID-19: The health authority said the bivalent mRNA vaccines are not new vaccines, but like the seasonal flu vaccines, they are updated to take into account the new form of virus circulating during the winter season.

French health authority approves Omicron-adapted vaccines for booster shot - Vimarsana News

French health authority approves Omicron-adapted vaccines for booster shot

PARIS, Sept. 20 (Xinhua) -- The French national health authority (HAS) approved on Tuesday three bivalent mRNA vaccines against the COVID-19 Omicron variants fo

Exclusive: Coronavirus: BioNTech vaccine for children may be available in Hong Kong as early as October - Vimarsana News

Exclusive: Coronavirus: BioNTech vaccine for children may be available in Hong Kong as early as October

Insider says local distributor of German-made vaccine has provided clinical data to health authorities, launching weeks-long approval process.

Source: scmp.com